FDA approves polypill Widaplik for hypertension

Updated on: July 10,2025 0

FDA approves polypill Widaplik for hypertension

Updated on:July 10,2025 0

FDA plans to use AI to speed up drug and food safety reviews

Updated on: July 11,2025 0

FDA plans to use AI to speed up drug and food safety reviews

Updated on:July 11,2025 0

Hyperinsulinemia linked to abnormal uterine bleeding

Updated on: July 13,2025 0

Hyperinsulinemia linked to abnormal uterine bleeding

Updated on:July 13,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on: October 02,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on:October 02,2025 0

Why the appendix is much more important than we once thought

Updated on: July 10,2025 0

Why the appendix is much more important than we once thought

Updated on:July 10,2025 0

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

Updated on: October 06,2025 0

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

Updated on:October 06,2025 0

A new way to treat cancer: Targeting the Hedgehog protein's hidden weakness

Updated on: August 11,2025 0

A new way to treat cancer: Targeting the Hedgehog protein's hidden weakness

Updated on:August 11,2025 0

Novel immunotherapy strategy shows promising long-term survival in certain advanced NSCLC patients

Updated on: October 06,2025 0

Novel immunotherapy strategy shows promising long-term survival in certain advanced NSCLC patients

Updated on:October 06,2025 0

Study finds decline in long-term benzodiazepine use among older adults, but risks remain

Updated on: September 30,2025 0

Study finds decline in long-term benzodiazepine use among older adults, but risks remain

Updated on:September 30,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on: October 05,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on:October 05,2025 0